FreeOx opens funding round of €2,5 million to finance ischemic stroke therapy

by FreeOx Biotech

FreeOx has developed the first cerebroprotective therapy designed to preserve the brain during acute ischemic stroke. It is the key piece in stroke treatment, as it focuses on microcirculation and sol...

Read more

ORYZON strengthens patent portfolio for iadademstat with European grant decision covering combinations with PD1/PD-L1 inhibitors

by Oryzon Genomics

Oryzon Genomics today announced that the European Patent Office (EPO) has issued a Decision to Grant for its patent application EP20712594.9, entitled “Combinations of iadademstat for cancer therapy...

Read more

Nanoligent closes €12 million funding round to advance the development of its oncology nanodrug

by Nanoligent

Nanoligent is a company whose goal is to develop new anticancer drugs specifically targeting aggressive tumors, using a pioneering technological platform based on protein–drug nanoconjugates. The co...

Read more

Sant Pau Participates in an International Gene Therapy Trial for Wet Macular Degeneration

by Hospital de la Santa Creu i Sant Pau

The Ophthalmology Department of Hospital de Sant Pau, together with the Ophthalmology Research Group of the Sant Pau Research Institute (IR Sant Pau), has recently participated in an international cli...

Read more

Overcoming Bottlenecks in Downstream Processing

by 53Biologics

In biologics manufacturing, upstream production often captures much of the spotlight. Fermentation, cell culture and expression systems are frequently discussed as the heart of drug development. Yet, ...

Read more

CDTI Innovación invests in Ona Therapeutics, together with five co-investors

by Professional Newco

Ona Therapeutics is a pioneer in the development of first-in-class antibody-drug conjugates (ADCs) that leverage the molecular basis of advanced cancer. Through collaboration with academic and clinica...

Read more

La AEMPS amplía el procedimiento de evaluación acelerada para ensayos de fases tempranas

by Sermes CRO

La Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) ha anunciado la ampliación de su procedimiento de evaluación acelerada para ensayos clínicos en fases tempranas, una medida que c...

Read more

Case Study: Accelerating Protocol Development for a European Biotech’s Bi-Specific Antibody Program

by Pivotal

El equipo médico oncológico de Pivotal, con amplia experiencia en estudios de fase inicial y redacción médica, asumió el reto de acelerar el desarrollo del protocolo y garantizar un inicio regula...

Read more

Nanoligent, a Spin-Off from IR Sant Pau and UAB, Raises €12 Million to Bring a CXCR4-Targeted Nanodrug to the Clinic

by Hospital de la Santa Creu i Sant Pau

Nanoligent, a spin-off from the Institut de Recerca Sant Pau (IR Sant Pau) and the Universitat Autnoma de Barcelona (UAB), has closed a €12 million funding round led by Inveready to advance the deve...

Read more

From Research Stage to GMP Production

by 3PBIOVIAN

Although operating under GMP standards is time-consuming and resource-intensive compared to working in a research setting, it is necessary for patient safety. These legally enforced GMP regulations re...

Read more

Fármaco en ensayo contra el principal oncogén en cáncer de páncreas: pequeño paso para pacientes, gran salto para la investigación

by CNIO - Centro Nacional de Investigaciones Oncológicas

Un estudio del Centro Nacional de Investigaciones Oncológicas (CNIO) ayuda a entender cómo funcionan los nuevos fármacos que bloquean el oncogén KRAS, mutado en un alto porcentaje de cánceres de ...

Read more

ORYZON receives feedback from the FDA in response to the submitted Phase III protocol in Borderline Personality Disorder

by Oryzon Genomics

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, BME: ORY), a clinical-stage biopharmaceutical company and global leader in epigenetics, today announced that it has received written feedback from the U...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Telum Therapeutics Secures €18 Million...

by Telum Therapeutics

Telum Therapeutics, a biotechnology company leveraging proprietary met...

Photos Stream